Effects of bone remodeling agents following teriparatide treatment

ConclusionsPatients who elected to discontinue osteoporosis treatment experienced a significant decline in the change in BMD compared to the change on teriparatide putting them at higher risk for recurrence of fragility fractures. Patients on denosumab following teriparatide had the largest increase in BMD.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research